华软科技(002453) - 2021 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2021 reached ¥1,124,850,127.39, representing a 73.28% increase year-over-year[5] - Net profit attributable to shareholders was ¥46,161,199.73, a significant increase of 1,177.40% compared to the same period last year[5] - The net profit after deducting non-recurring gains and losses was ¥38,418,093.82, up 281.99% year-over-year[5] - The basic earnings per share for the period was ¥0.0593, reflecting an increase of 841.27% compared to the previous year[7] - The company reported a net loss of ¥-258,774,099.57, an improvement from ¥-324,581,512.01 in the previous year[36] - The total profit for the current period is approximately ¥84.04 million, compared to ¥32.59 million in the previous period, indicating a year-over-year increase of 157.5%[40] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥3,656,663,664.83, a 27.03% increase from the end of the previous year[7] - Current assets totaled ¥1,901,677,554.19, up from ¥1,181,586,416.36, reflecting a growth of 61.0% year-over-year[30] - Total liabilities increased to ¥1,254,962,193.38 from ¥1,180,398,818.01, reflecting a rise of 6.3%[36] - Total liabilities included a 197.41% increase in notes payable, amounting to CNY 27,599,990.00, reflecting the expansion of business scale[12] - Total equity attributable to shareholders of the parent company is approximately $1.58 billion[58] - Total liabilities and equity amount to approximately $2.88 billion[58] Cash Flow - The net cash flow from operating activities for the year-to-date was -¥118,940,786.38, a decline of 164.09%[7] - Cash flow from operating activities showed a net outflow of CNY 118,940,786.38, a decline of 164.09% compared to a net inflow of CNY 185,590,321.23 in the previous year[12] - The company generated cash inflow from operating activities totaling approximately ¥2.91 billion, compared to ¥2.23 billion in the previous period, an increase of 30.4%[46] - Cash flow from financing activities generated a net amount of 549,119,884.73, compared to -357,091,021.79 in the previous period[49] - The net increase in cash and cash equivalents was 330,600,688.95, up from 21,395,359.30[49] Investments and Acquisitions - The company completed the acquisition of 98.94% equity in Beijing Aodexi Chemical Co., Ltd., with a total transaction value of approximately RMB 97.14 million, increasing the total share capital to 778,414,117 shares[20] - The company invested ¥21,370,781.09 in development expenses, up from ¥14,516,468.33, indicating a growth of 47.5%[33] - The company has received RMB 50.36 million as the first payment under a settlement agreement related to a previous equity transfer dispute[21] Shareholder Equity - Shareholders' equity attributable to the parent company was ¥2,287,238,310.88, up 44.65% from the previous year[7] - Owner's equity totaled ¥2,401,701,471.45, compared to ¥1,698,293,451.12, representing a growth of 41.5%[36] - The company has a surplus reserve of approximately $27.34 million[58] Research and Development - Research and development expenses increased by 127.73% to CNY 12,413,656.04, primarily due to the consolidation of Aodex Chemical's R&D costs[12] - Research and development expenses increased to approximately ¥12.41 million from ¥5.45 million, representing a year-over-year increase of 128.5%[40] Government Support - The company received government subsidies amounting to ¥1,627,259.10 during the reporting period[8] Miscellaneous - The company has not undergone an audit for the third quarter report[58] - The company has established a special account for raised funds with ICBC, ensuring proper management of the funds[26]